Retatrutide (GLP-3RT) research compound vial

Retatrutide (GLP-3RT)

10mg
£54.99
Sale price  £54.99 Regular price 
Skip to product information
Retatrutide (GLP-3RT) research compound vial

Retatrutide (GLP-3RT)

£54.99
Sale price  £54.99 Regular price 
MG

Retatrutide, supplied here under our existing identifier GLP-3RT (development code LY3437943), is an investigational peptide studied for simultaneous agonist activity at the GIP, GLP-1 and glucagon receptors — commonly described in the literature as a triple receptor agonist. Available in 10 mg and 20 mg vials, each batch is supplied as lyophilised powder and tested to the purity levels confirmed below. Reliable Research Labs supplies Retatrutide (GLP-3RT) from the UK strictly for qualified laboratory research — see "About Retatrutide" below for further scientific background.
Not Intended for Human or Animal Consumption

PRODUCT SPECIFICATIONS

  • Available strengths: 10 mg and 20 mg
  • Appearance: Lyophilized (Freeze-Dried) Powder
  • Purity: ≥99.6% (Confirmed by HPLC Analysis)

RESEARCH USE

This material is supplied exclusively for laboratory-based, in vitro research conducted by qualified professionals. It is not approved for use in humans or animals and must not be incorporated into pharmaceuticals, dietary supplements, food products, cosmetics, or diagnostic applications.

IMPORTANT NOTICE

This product has not been reviewed or approved by the U.S. Food and Drug Administration (FDA). No claims are made regarding safety, efficacy, or therapeutic benefit. It is not intended to diagnose, treat, cure, or prevent any medical condition. Researchers are responsible for ensuring all work complies with applicable laws, regulations, and institutional protocols.

PURCHASE AGREEMENT

By completing a purchase, the customer confirms that they are a qualified researcher, laboratory, educational institution, or authorized organization purchasing this product solely for lawful research purposes. The purchaser accepts full responsibility for the proper storage, handling, use, and disposal of the product, as well as compliance with all applicable local, state, and federal regulations. All sales are considered final unless otherwise stated.

About Retatrutide

Retatrutide (development code LY3437943) is an investigational peptide studied for simultaneous agonist activity at three metabolic receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor. This triple receptor agonist mechanism distinguishes Retatrutide from single- or dual-receptor incretin-based compounds, and is the primary reason it has attracted substantial research interest in metabolic and endocrine science.

Research has examined how combined GIP, GLP-1 and glucagon receptor activity influences metabolic signalling pathways relevant to energy balance and glucose regulation, making Retatrutide a frequently referenced compound in comparative metabolic receptor research.

At Reliable Research Labs, Retatrutide is supplied under our existing identifier GLP-3RT, strictly as a laboratory research compound. For related compounds and broader background on peptide research, see our peptide Compound Library.

What Effects of Retatrutide Are Studied?

As a triple GIP/GLP-1/glucagon receptor agonist, Retatrutide has been investigated in clinical and preclinical research for its influence on metabolic signalling, including glucose and lipid metabolism, appetite and energy-intake regulation, and body-weight-related outcomes reported in clinical trial literature. Its combined receptor activity is of particular interest to researchers comparing it against single- and dual-agonist compounds in metabolic research.

Retatrutide remains an investigational compound. It is not an approved medicine, and research findings to date describe outcomes observed in clinical and preclinical study populations, not guaranteed effects for any individual.

Reliable Research Labs supplies Retatrutide (GLP-3RT) exclusively for qualified laboratory research — nothing on this page describes, recommends or implies dosing, administration or an outcome from using this product.

Customer Reviews

You may also like